Department of Medical Pharmacology, Gulhane Military Academy of Medicine, Ankara, Turkey.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):97-105. doi: 10.1016/j.pnpbp.2012.01.007. Epub 2012 Jan 24.
Cannabinoids produce antinociceptive and antihyperalgesic effects mainly through activation of the inhibitory CB1 receptors. The demonstration that antinociceptive effects of systemic cannabinoids are significantly diminished following surgical dorsolateral funiculus lesion provides evidence that supraspinal sites and descending pain modulatory pathways play crucial roles in systemic cannabinoid analgesia. In this review, we will firstly provide a background, brief overview of descending modulatory pathways followed by descending pathways implicated in cannabinoid analgesia. We will then describe the recent evidence of the involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. This review will provide evidences that systemically administered cannabinoids reinforce the descending serotonergic and noradrenergic pathways to produce acute antinociceptive effects via spinal 5-HT7, 5-HT2A and alpha-2 adrenoceptors activation.
大麻素主要通过激活抑制性 CB1 受体产生镇痛和抗痛觉过敏作用。系统大麻素的镇痛作用在背外侧束损伤后明显减弱的证明提供了证据,表明脊髓上部位和下行疼痛调制途径在系统大麻素镇痛中起关键作用。在这篇综述中,我们将首先提供背景,简要概述下行调制途径,然后描述下行途径在大麻素镇痛中的作用。然后,我们将描述涉及下行 5-羟色胺能和去甲肾上腺素能途径的最近证据在 CB1 受体介导的镇痛作用。这篇综述提供的证据表明,系统给予大麻素通过激活脊髓 5-HT7、5-HT2A 和α-2 肾上腺素能受体来增强下行 5-羟色胺能和去甲肾上腺素能途径,从而产生急性镇痛作用。